The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome
Abstract
Background: Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and the related technique, surface-enhanced laser desorption/ionization (SELDI)-TOF MS, are being applied widely to analyze serum or plasma specimens for potential disease markers. Methods: Reports on the basic principles and applications of MALDI-TOF MS were reviewed and related to information on abundance and masses of major plasma proteins. Outcomes: MALDI-TOF MS is a particle-counting method that responds to molar abundance, and ranking of plasma proteins by molar abundance increases the rank of small proteins relative to traditional ranking by mass abundance. Detectors for MALDI-TOF MS augment the bias for detecting smaller components by yielding stronger signals for an equivalent number of small vs large ions. Consequently, MALDI-TOF MS is a powerful tool for surveying small proteins and peptides comprising the peptidome or fragmentome, opening this new realm for analysis. It is complementary to techniques such as electrophoresis and HPLC, which have a bias for detecting larger molecules. Virtually all of the potential markers identified by MALDI-TOF MS to date represent forms of the most abundant plasma proteins. Conclusions: Analyses of serum or plasma by MALDI-TOF MS provide new information mainly about small proteins and peptides with high molar abundance. The spectrum of observed proteins and peptides suggests value for applications such as assessment of cardiovascular risk, nutritional status, liver injury, kidney failure, and systemic immune responses rather than early detection of cancer. Extending analysis by MALDI-TOF MS to lower abundance components, such as markers for early-stage cancers, probably will require more extensive specimen fractionation before analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons
Karas, M., & Hillenkamp, F. (1988) · Analytical Chemistry · doi:10.1021/ac00171a028 · Cited by 5,637
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Protein and polymer analyses up to m/z 100 000 by laser ionization time‐of‐flight mass spectrometry
Tanaka, K., Waki, H., Ido, Y., Akita, S., Yoshida, Y., Yoshida, T., & Matsuo, T. (1988) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1290020802 · Cited by 3,175
Tietz Textbook of Clinical Chemistry
(1999) · Archives of Pathology and Laboratory Medicine · doi:10.5858/123.7.646b · Cited by 2,495
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Ion Suppression in Mass Spectrometry
Annesley, T. M. (2003) · Clinical Chemistry · doi:10.1373/49.7.1041 · Cited by 1,591
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
Kushner, I. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22124.x · Cited by 1,479
Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300127-mcp200 · Cited by 1,006
Zhang, Z., Bast, R. C., Yu, Y., Li, J., Sokoll, L. J., Rai, A. J., Rosenzweig, J. M., Cameron, B., Wang, Y. Y., Meng, X.-Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0746 · Cited by 934
Coppinger, J. A., Cagney, G., Toomey, S., Kislinger, T., Belton, O., McRedmond, J. P., Cahill, D. J., Emili, A., Fitzgerald, D. J., & Maguire, P. B. (2004) · Blood · doi:10.1182/blood-2003-08-2804 · Cited by 814
Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500358 · Cited by 787
Differential exoprotease activities confer tumor-specific serum peptidome patterns
Villanueva, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26022 · Cited by 741
Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine
Bradwell, A. R., Carr-Smith, H. D., Mead, G. P., Tang, L. X., Showell, P. J., Drayson, M. T., & Drew, R. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.673 · Cited by 650
Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool
Diamandis, E. P. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400007-mcp200 · Cited by 631
Karas, M., Gl�ckmann, M., & Sch�fer, J. (2000) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(200001)35:1<1::aid-jms904>3.0.co;2-0 · Cited by 614
Adam, B.-L., Qu, Y., Davis, J. W., Ward, M. D., Clements, M. A., Cazares, L. H., Semmes, O. J., Schellhammer, P. F., Yasui, Y., Feng, Z., et al. (2002) · PubMed · Cited by 612
Rai, A. J., Gelfand, C. A., Haywood, B. C., Warunek, D. J., Yi, J., Schuchard, M. D., Mehigh, R. J., Cockrill, S. L., Scott, G. B. I., Tammen, H., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200401245 · Cited by 545
Structure and Biological Role of Vitronectin
Preissner, K. T. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.001423 · Cited by 486
Villanueva, J., Philip, J., Entenberg, D., Chaparro, C. A., Tanwar, M. K., Holland, E. C., & Tempst, P. (2004) · Analytical Chemistry · doi:10.1021/ac0352171 · Cited by 449
Molecular Basis of Proteinuria of Glomerular Origin
Brenner, B. M., Hostetter, T. H., & Humes, H. D. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804132981507 · Cited by 446
Current developments in SELDI affinity technology
Tang, N., Tornatore, P., & Weinberger, S. R. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.10066 · Cited by 425
[1] Introduction to the plasma lipoproteins
Gotto, A. M., Pownall, H. J., & Havel, R. J. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)28061-1 · Cited by 421
Weighing Naked Proteins: Practical, High-Accuracy Mass Measurement of Peptides and Proteins
Chait, B. T., & Kent, S. B. H. (1992) · Science · doi:10.1126/science.1411504 · Cited by 393
Brown, R. S., & Lennon, J. J. (1995) · Analytical Chemistry · doi:10.1021/ac00109a015 · Cited by 371
Semmes, O. J., Feng, Z., Adam, B.-L., Banez, L. L., Bigbee, W. L., Campos, D., Cazares, L. H., Chan, D. W., Grizzle, W. E., Izbicka, E., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.038950 · Cited by 343
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
Lozier, J., Takahashi, N., & Putnam, F. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3640 · Cited by 323
Characterization of serum biomarkers for detection of early stage ovarian cancer
Kozak, K. R., Su, F., Whitelegge, J. P., Faull, K., Reddy, S., & Farias‐Eisner, R. (2005) · PROTEOMICS · doi:10.1002/pmic.200500093 · Cited by 311
Schultz, D. R., & Arnold, P. I. (1990) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(90)90055-k · Cited by 293
The Dominance of Arginine-Containing Peptides in MALDI-Derived Tryptic Mass Fingerprints of Proteins
Krause, E., Wenschuh, H., & Jungblut, P. R. (1999) · Analytical Chemistry · doi:10.1021/ac990298f · Cited by 287
Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold
Liotta, L. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27467 · Cited by 251
Banks, R. E., Stanley, A. J., Cairns, D. A., Barrett, J. H., Clarke, P., Thompson, D., & Selby, P. J. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.051417 · Cited by 240
Processing of Serum Proteins Underlies the Mass Spectral Fingerprinting of Myocardial Infarction
Marshall, J., Kupchak, P., Zhu, W., Yantha, J., Vrees, T., Furesz, S., Jacks, K., Smith, C., Kireeva, I., Zhang, R., et al. (2003) · Journal of Proteome Research · doi:10.1021/pr030003l · Cited by 229
Koomen, J. M., Li, D., Xiao, L.-C., Liu, T. C., Coombes, K. R., Abbruzzese, J., & Kobayashi, R. (2005) · Journal of Proteome Research · doi:10.1021/pr050046x · Cited by 223
Baumann, S., Ceglarek, U., Fiedler, G. M., Lembcke, J., Leichtle, A., & Thiery, J. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.047308 · Cited by 219
Cho, W. C. S., Yip, T. T. C., Yip, C., Yip, V., Thulasiraman, V., Ngan, R. K. C., Yip, T.-T., Lau, W.-H., Au, J. S. K., Law, S. C. K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0413-3 · Cited by 207
Tolson, J., Bogumil, R., Brunst, E., Beck, H., Elsner, R., Humeny, A., Kratzin, H., Deeg, M., Kuczyk, M., Mueller, G. A., et al. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700097 · Cited by 198
Analysis of Albumin-Associated Peptides and Proteins from Ovarian Cancer Patients
Lowenthal, M. S., Mehta, A. I., Frogale, K., Bandle, R. W., Araujo, R. P., Hood, B. L., Veenstra, T. D., Conrads, T. P., Goldsmith, P., Fishman, D., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.052944 · Cited by 194
Composition of the peptide fraction in human blood plasma: database of circulating human peptides
Richter, R., Schulz-Knappe, P., Schrader, M., Ständker, L., Jürgens, M., Tammen, H., & Forssmann, W.-G. (1999) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00012-2 · Cited by 193
Investigating diversity in human plasma proteins
Nedelkov, D., Kiernan, U. A., Niederkofler, E. E., Tubbs, K. A., & Nelson, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500426102 · Cited by 192
Independent Validation of Candidate Breast Cancer Serum Biomarkers Identified by Mass Spectrometry
Li, J., Orlandi, R., White, C. N., Rosenzweig, J., Zhao, J., Seregni, E., Morelli, D., Yu, Y., Meng, X.-Y., Zhang, Z., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.052878 · Cited by 183
Derivatization for Stabilizing Sialic Acids in MALDI-MS
Sekiya, S., Wada, Y., & Tanaka, K. (2005) · Analytical Chemistry · doi:10.1021/ac050287o · Cited by 175
Hu, J. (2005) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/3.4.322 · Cited by 174
Koomen, J. M., Shih, L. N., Coombes, K. R., Li, D., Xiao, L.-C., Fidler, I. J., Abbruzzese, J. L., & Kobayashi, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1110.11.3 · Cited by 165
Plasma protein secretion by the liver
Glaumann, H., Peters, T., & Redman, C. M. (1983) · Academic Press eBooks · Cited by 163
Önnerfjord, P., Heathfield, T. F., & Heinegård, D. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308689200 · Cited by 162
Serum Levels of an Isoform of Apolipoprotein A-II as a Potential Marker for Prostate Cancer
Malik, G., Ward, M. D., Gupta, S. K., Trosset, M. W., Grizzle, W. E., Adam, B.-L., Diaz, J. I., & Semmes, O. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1073.11.3 · Cited by 158
Haab, B. B., Geierstanger, B. H., Michailidis, G. C., Vitzthum, F., Forrester, S., Okon, R., Saviranta, P., Brinker, A., Sorette, M. P., Perlee, L. T., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200401276 · Cited by 151
Possible Detection of Pancreatic Cancer by Plasma Protein Profiling
Honda, K., Hayashida, Y., Umaki, T., Okusaka, T., Kosuge, T., Kikuchi, S., Endo, M., Tsuchida, A., Aoki, T., Itoi, T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1851 · Cited by 146
Allard, L., Lescuyer, P., Burgess, J., Leung, K., Ward, M. A., Walter, N., Burkhard, P. R., Corthals, G. L., Hochstrasser, D. F., & Sanchez, J. (2004) · PROTEOMICS · doi:10.1002/pmic.200300809 · Cited by 140
Cheng, A., Chen, L.-C., Chien, K., Chen, Y., Chang, J. T., Wang, H., Liao, C., & Chen, I. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.052324 · Cited by 138
Lopez, M. F., Mikulskis, A., Kuzdzal, S. A., Bennett, D. A., Kelly, J., Golenko, E. E., DiCesare, J. L., Denoyer, E. R., Patton, W. F., Ediger, R., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.053090 · Cited by 137
Gonçalvès, A., Esterni, B., Bertucci, F., Sauvan, R., Chabannon, C., Cubizolles, M., Bardou, V. J., Houvenaegel, G., Jacquemier, J. D., Granjeaud, S., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209131 · Cited by 131
Kratzer, R., Eckerskorn, C., Karas, M., & Lottspeich, F. (1998) · Electrophoresis · doi:10.1002/elps.1150191109 · Cited by 127
An Integrated Study of Fibrinogen during Blood Coagulation
Brummel, K. E., Butenas, S., & Mann, K. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22862 · Cited by 126
Rapid Identification of Hemoglobin Variants by Electrospray Ionization Mass Spectrometry
Wild, B. J., Green, B. N., Cooper, E., Lalloz, M. R. A., Erten, S., Stephens, A. D., & Layton, D. M. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0430 · Cited by 122
Le, L., Chi, K., Tyldesley, S. K., Flibotte, S., Diamond, D. L., Kuzyk, M. A., & Sadar, M. D. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.041087 · Cited by 122
Gilár, M., Bouvier, E. S. P., & Compton, B. J. (2001) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)01108-0 · Cited by 118
Analytical and Preanalytical Biases in Serum Proteomic Pattern Analysis for Breast Cancer Diagnosis
Karsan, A., Eigl, B. J., Flibotte, S., Gelmon, K. A., Switzer, P., Hassell, P., Harrison, D., Law, J. H., Hayes, M. M., Stillwell, M., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050708 · Cited by 116
MALDI Mass Spectrometry for Direct Tissue Analysis: A New Tool for Biomarker Discovery
Reyzer, M. L., & Caprioli, R. M. (2005) · Journal of Proteome Research · doi:10.1021/pr050095+ · Cited by 115
Ishioka, N., Takahashi, N., & Putnam, F. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2363 · Cited by 114
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1
Moshkovskii, S. A., Serebryakova, M. V., Kuteykin‐Teplyakov, K. B., Tikhonova, O. V., Goufman, E., Zgoda, V. G., In, T., Макаров, О. В., & Archakov, A. I. (2005) · PROTEOMICS · doi:10.1002/pmic.200401205 · Cited by 111
Plasma Protein Profiling by Mass Spectrometry for Cancer Diagnosis: Opportunities and Limitations
Diamandis, E. P., & van der Merwe, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.963.11.3 · Cited by 111
Drake, S. K., Bowen, R. A. R., Remaley, A. T., & Hortin, G. L. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.040303 · Cited by 107
Self-citationSokoll, L. J., Wians, F. H., & Remaley, A. T. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.030817 · Cited by 100
Can Mass Spectrometric Protein Profiling Meet Desired Standards of Clinical Laboratory Practice?
Hortin, G. L. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.043281 · Cited by 91
Self-citationNomura, F., Tomonaga, T., Sogawa, K., Ōhashi, T., Nezu, M., Sunaga, M., Kondo, N., Iyo, M., Shimada, H., & Ochiai, T. (2004) · PROTEOMICS · doi:10.1002/pmic.200300674 · Cited by 89
Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome
Pang, R. T. K., Poon, T. C. W., Chan, K. A., Lee, N. L. S., Chiu, R. W. K., Tong, Y., Wong, R. M. Y., Chim, S. S. C., Ngai, S. M., Sung, J. J. �., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061689 · Cited by 88
Rai, A. J., Stemmer, P. M., Zhang, Z., Adam, B.-L., Morgan, W. T., Caffrey, R., Podust, V. N., Patel, M., Lim, L., Shipulina, N. V., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200401320 · Cited by 86
Ikewaki, K., Rader, D., Schaefer, J., Fairwell, T., Zech, L. A., & Brewer, H. B. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35361-x · Cited by 86
Proteomics: The next revolution in laboratory medicine?
Plebani, M. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.017 · Cited by 83
Alpha, Beta, Gamma, Omega — The Roster of the Plasma Proteins
Putnam, F. W. (1975) · Elsevier eBooks · doi:10.1016/b978-0-12-568401-9.50009-8 · Cited by 80
Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein
Bondarenko, P. V., Cockrill, S. L., Watkins, L. K., Cruzado, I. D., & Macfarlane, R. D. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32459-7 · Cited by 79
Ahn, W., Sung‐Pil, P., Bae, S.-M., Joon‐Mo, L., Sung-Eun, N., Nam, G. H., Young‐Lae, C., Ho‐Sun, C., Heung‐Jae, J., Chong‐Kook, K., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00029.x · Cited by 76
Schweigert�, F. J., Wirth, K., & Raila, J. (2004) · Proteome Science · doi:10.1186/1477-5956-2-5 · Cited by 75
Vermeulen, R. C. H., Lan, Q., Zhang, L., Gunn, L., McCarthy, D., Woodbury, R. L., McGuire, M., Podust, V. N., Li, G., Chatterjee, N., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508573102 · Cited by 70
Albumin affinity tags increase peptide half-life in vivo
Koehler, M. F. T., Zobel, K., Beresini, M. H., Caris, L. D., Combs, D. L., Paasch, B. D., & Lazarus, R. A. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00610-8 · Cited by 65
Diverse range of small peptides associated with high-density lipoprotein
Hortin, G. L., Shen, R., Martin, B. M., & Remaley, A. T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.098 · Cited by 61
Self-citationSeldi-Tof Mass Spectrometry for Cancer Biomarker Discovery and Serum Proteomic Diagnostics
Simpkins, F. A., Czechowicz, J. A., Liotta, L. A., & Kohn, E. C. (2005) · Pharmacogenomics · doi:10.2217/14622416.6.6.647 · Cited by 48
Aivado, M. A., Spentzos, D., Alterovitz, G., Otu, H. H., Grall, F. T., Giagounidis, A. A. N., Wells, M., Cho, J., Germing, U., Czibere, A. G., et al. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.022 · Cited by 48
Tammen, H., Schulte, I., Hess, R., et al. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620705774962508 · Cited by 47
Traum, A. Z., Wells, M. P., Aivado, M. A., Libermann, T. A., Ramoni, M. F., & Schachter, A. D. (2006) · PROTEOMICS · doi:10.1002/pmic.200500174 · Cited by 46
Nepomuceno, A. I., Mason, C. J., Muddiman, D. C., Bergen, H. R., & Zeldenrust, S. R. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.033274 · Cited by 46
Inflammatory protein profile during systemic high dose interleukin‐2 administration
Rossi, L., Martin, B. M., Hortin, G. L., White, R. L., Foster, M., Moharram, R., Stroncek, D. F., Wang, E., Marincola, F. M., & Panelli, M. C. (2005) · PROTEOMICS · doi:10.1002/pmic.200500004 · Cited by 37
Self-citationOnline Single-Step Analysis of Blood Proteins: The Transferrin Story
Bergen, H. R., Lacey, J. M., O’Brien, J. F., & Naylor, S. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5232 · Cited by 32
Sottani, C., Fiorentino, M., & Minoia, C. (1997) · Rapid Communications in Mass Spectrometry · doi:10.1002/(sici)1097-0231(199705)11:8<907::aid-rcm899>3.0.co;2-0 · Cited by 31
Ikewaki, K., Zech, L. A., Brewer, H. B., & Rader, D. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37626-4 · Cited by 29
Phosphate ester serum albumin affinity tags greatly improve peptide half-life in vivo
Zobel, K., Koehler, M. F. T., Beresini, M. H., Caris, L. D., & Combs, D. L. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00209-9 · Cited by 26
Sexton, C. W., Buss, D., Powell, B. L., et al. (1996) · Leukemia Research · doi:10.1016/0145-2126(96)00001-x · Cited by 24
Bard, E., Laibe, S., Bettinger, D., Riethmuller, D., Biichlé, S., Seillès, E., & Meillet, D. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.021 · Cited by 22
Application of Bioaffinity Mass Spectrometry for Analysis of Ligands
Zhu, Y., Valdes, R., & Jortani, S. A. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000179851.32093.dc · Cited by 12
Detection of human MCP-4/CCL13 isoforms by SELDI immunoaffinity capture
Rossi, L., Moharram, R., Martin, B. M., White, R. L., & Panelli, M. C. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-5 · Cited by 8
Cited by
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700465 · Cited by 777
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie · doi:10.1002/ange.200700465 · Cited by 655
Molecular mechanisms of hepatocellular carcinoma
Aravalli, R. N., Steer, C. J., & Cressman, E. N. K. (2008) · Hepatology · doi:10.1002/hep.22580 · Cited by 625
Sparvero, L. J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A. A., Zeh, H. J., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-17 · Cited by 622
The blood peptidome: a higher dimension of information content for cancer biomarker discovery
Petricoin, E. F., Belluco, C., Araujo, R. P., & Liotta, L. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2011 · Cited by 357
Metadata
- Authors
- Hortin, G. L.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-01
- Volume
- 52
- Issue
- 7
- Pages
- 1223-1237
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2112909603
- Cited by
- 351
- References
- 95
- FWCI
- 17.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.